Elanco reports solid quarter but global concerns lead to drop in share price
Several analysts said Elanco faces a bright future, implying that the market might be overreacting to the lowered revenue and profit guidance.
Health Care & Life Sciences
Articles
Pablo Svirsky: Shipping times for some supplies may never return to old levels
It should come as no surprise that pandemic-related supply chain challenges have also had a major impact on the life sciences industry.
Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
Pandemic continued to financially punish Indiana hospitals in 1st quarter
Indiana University Health lost $29.8 million, and Community Health lost $28.5 million during the quarter, as both systems postponed surgeries to deal with the rising number of COVID-19 cases.
Lilly profit soars 40% in first quarter
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Indiana life sciences companies landed $15B in funding in 2021
The funding included 39 Indiana life-science companies raising $433.5 million last year in venture capital, an increase of almost $200 million compared to 2020, according to a report issued by BioCrossroads.
Indianapolis-based Telix rolls out method for detecting cancer
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.
Indy-based Acacia Pharma being acquired by New Jersey firm; fate of local operations unknown
Acacia Pharma Group employees are waiting to see what will happen to their jobs and whether the company will remain in Indianapolis in any form, now that it is being acquired by New Jersey-based specialty drugmaker Eagle Pharmaceuticals Inc. for $103.9 million.
Lilly says it will push ahead on Alzheimer’s drug
The push by Eli Lilly and Co. will come despite an unfavorable ruling last week from Medicare that sharply restricts reimbursements for a drug in the same class.
Purdue research led to FDA-approved treatment of advanced prostate cancer
Brooke Beier, senior vice president of commercialization at the Purdue Research Foundation, said FDA approval of the therapy is one of the most meaningful approvals ever for a Purdue-related innovation.
Financial challenges plague rural hospitals, including in Indiana
Rural hospitals have long struggled to stay afloat. But now, the sector is facing a wave of closings under additional financial pressures, some caused by the pandemic that has strained resources.
GeniPhys wins nearly $1M grant to commercialize tissue restoration technology
The West Lafayette life sciences company was awarded the $974,349 grant to further the development of a core technology known as Collymer. It can be used to create implantable materials for tissue restoration and reconstruction needs such as breast tissue, skeletal muscle, cartilage and more.
Cook Medical legal battle one of largest in state history
The medical-device maker is vigorously defending itself against a mountain of lawsuits that claim its inferior vena cava (IVC) filters, designed to catch blood clots, are unsafe.
Eli Lilly’s Alzheimer’s drug hits roadblock
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
Q&A with Kellie Tremain on the importance of organ donation
Tremain has been president of the Indiana Donor Network since 2012, and coaxes people at every opportunity to consider donating their organs after they die to others who need a kidney, liver, heart or other organ.
Indiana life science companies land a record $433M in venture capital in 2021
Indiana’s life-sciences sector, often hailed as a key driver of the state’s economy, landed a record $433 million in venture funding last year, despite the COVID-19 pandemic that challenged so many other sectors, from restaurants to airlines.
Assessment and Intervention Center takes on broad mandate
Originally intended to divert low-level, nonviolent offenders from criminal justice apparatus, the AIC has assessed 1,700 residents for struggles with mental health or substance abuse disorders.
Catching COVID on a business trip can get complicated
Not only do you have to rearrange plans to visit customers or attend conferences, but you suddenly need to isolate in a hotel room, find restaurants that deliver, and perhaps reschedule flight and hotel plans.
Crowded ERs divert ambulances in huge numbers, state data shows
Central Indiana hospitals diverted ambulances for nearly 3,000 hours during a six-week period this fall, according to information IBJ received from the Indiana State Department of Health through an open-records request.
Legislation pits religious freedoms against employer rights
For the past year, Indiana employers have faced the challenge of whether to enforce COVID-19 vaccination mandates on workers who say the vaccines violate their religious beliefs.